National Lipid Association (NLA) Scientific Sessions 2026

Topics

• Genetic Disorders (including Hereditary Dyslipidemias)
• Pathophysiology of Atherosclerosis (including Lipoprotein Metabolism)
• Epidemiology of Cardiovascular Disease
• Metabolic Syndrome, Insulin Resistance, Diabetes
• Comprehensive ASCVD Risk Reduction (including hypertension, smoking cessation)
• Inflammation in Atherosclerosis
• Gene Therapy
• Imaging
• Enhancing Adherence to Therapies (including Management of Statin Intolerance)
• Clinical Application of Biomarkers
• Novel Therapies in Lipid Management and Co-Morbidities
• HDL Modification or Novel HDL Therapies
• Lipid Management through Nutrition, Supplements and Lifestyle Therapies (including Omega-3 Fatty Acids)
• Best Practices in Lipid Management (including Clinical Operations, Team-based Care Approaches, Outcomes Research)
• Lipid Management in Special Populations (including COVID-19)
• Lipid Management through Pharmacology
• Diversity, Equity, and Inclusion- research or case studies highlighting underserved populations
• Complex or Unusual Cases in Lipid Management

Who should Attend

Attendees with an interest in lipid management including:

• Physician assistants
• Physicians
• Registered nurses
• Pharmacists
• Advance practice registered nurses
• Nurse practitioners
• Registered dietitians